AGL vs AUNA

The Advanced Deterministic Scorecard reveals a weak financial health profile with a Piotroski F-Score of 4/9, indicating borderline stability, and a missing Altman Z-Score prevents a full distress risk assessment. Profitability metrics are deeply negative, including a -5.24% profit margin, -8.86% operating margin, and a disastrous -73.31% ROE, signaling severe capital inefficiency. Despite a low Price/Sales ratio of 0.07 and a current price of $0.99, the company is unprofitable with declining revenue and negative earnings momentum, while the market has priced in extreme pessimism, as seen in a 5Y return of -96.8%. Analysts unanimously recommend a 'hold' with a target price equal to the current price, suggesting no near-term upside expectation.

AUNA exhibits a Piotroski F-Score of 6/9, indicating stable financial health, but lacks an Altman Z-Score, limiting distress risk assessment. The stock appears undervalued with a current price of $5.66 versus a Graham Number of $12.0, suggesting defensive fair value, though growth metrics are weak with negative earnings and revenue growth. Profitability margins and ROE are positive, but high debt/equity and declining earnings raise concerns. Analysts recommend a 'buy' with a target price of $8.77, implying upside potential, but recent price volatility and deteriorating fundamentals temper bullishness.